Last reviewed · How we verify
Flavanol
Flavanol is a Small molecule drug developed by Heinrich-Heine University, Duesseldorf. It is currently in Phase 1 development.
-
Baseline phase 1 → approval rate
+9.6pp
Industry-wide phase 1 drugs reach approval ~9.6% of the time (BIO/Informa 2023 industry benchmark across all therapeutic areas).
| Regulator | Country | Likely year | Lag vs FDA |
|---|---|---|---|
| FDA | US | 2033–2036 | — |
| EMA | EU | 2034–2037 | +0.7 yr |
| MHRA | GB | 2034–2037 | +0.7 yr |
| Health Canada | CA | 2034–2038 | +0.9 yr |
| TGA | AU | 2034–2038 | +1.2 yr |
| PMDA | JP | 2034–2038 | +1.5 yr |
| NMPA | CN | 2035–2039 | +2.3 yr |
| MFDS | KR | 2034–2038 | +1.4 yr |
| CDSCO | IN | 2034–2039 | +1.8 yr |
| ANVISA | BR | 2035–2039 | +2.3 yr |
Hover any row for the lag rationale. Lag estimates are reduced when the drug has FDA Breakthrough or EMA PRIME designation (sponsors file globally in parallel).
Estimate based on the BIO/Informa industry phase transition rates plus per-drug modifiers for therapeutic area, sponsor type, FDA designations, mechanism, and trial design. Per-jurisdiction lags from Tufts CSDD international approval studies. Not investment, clinical or regulatory advice. Methodology: /methodology#likelihood.
At a glance
| Generic name | Flavanol |
|---|---|
| Sponsor | Heinrich-Heine University, Duesseldorf |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Biomarker-estimated Flavanol Intake in Davis (FID)
- Chardonnay Marc and Vascular Response (NA)
- Can Cocoa Flavanols Protect Endothelial Function During Prolonged Sitting in Healthy Older Adults? (NA)
- Cocoa Extract for Migraine Trial (NA)
- Enhancing Recovery Through a Combined Mechanobiologic Intervention Following Meniscus Repair (PHASE2, PHASE3)
- The Acute Effects of Cocoa Flavanols Intake on Overt and Covert Attention (NA)
- Investigating the Effects of Green Tea on Blood Viscosity (NA)
- Comparison of the Bioavailability of the Flavanol of Grape Extracts (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Flavanol CI brief — competitive landscape report
- Flavanol updates RSS · CI watch RSS
- Heinrich-Heine University, Duesseldorf portfolio CI
Frequently asked questions about Flavanol
What is Flavanol?
Who makes Flavanol?
What development phase is Flavanol in?
Related
- Manufacturer: Heinrich-Heine University, Duesseldorf — full pipeline
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing